- Home
- NAGE vs IIIV Comparison
NAGE vs IIIV Comparison
Compare NAGE & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAGE
- IIIV
- Stock Information
- Founded
- NAGE 1999
- IIIV 2012
- Country
- NAGE United States
- IIIV United States
- Employees
- NAGE N/A
- IIIV N/A
- Industry
- NAGE Medicinal Chemicals and Botanical Products
- IIIV EDP Services
- Sector
- NAGE Health Care
- IIIV Technology
- Exchange
- NAGE Nasdaq
- IIIV Nasdaq
- Market Cap
- NAGE 766.4M
- IIIV 720.4M
- IPO Year
- NAGE N/A
- IIIV 2018
- Fundamental
- Price
- NAGE $7.42
- IIIV $31.92
- Analyst Decision
- NAGE Strong Buy
- IIIV Buy
- Analyst Count
- NAGE 3
- IIIV 6
- Target Price
- NAGE $17.00
- IIIV $34.33
- AVG Volume (30 Days)
- NAGE 1.2M
- IIIV 183.3K
- Earning Date
- NAGE 10-30-2025
- IIIV 11-17-2025
- Dividend Yield
- NAGE N/A
- IIIV N/A
- EPS Growth
- NAGE N/A
- IIIV N/A
- EPS
- NAGE 0.22
- IIIV 5.56
- Revenue
- NAGE $116,303,000.00
- IIIV $248,271,000.00
- Revenue This Year
- NAGE $28.91
- IIIV N/A
- Revenue Next Year
- NAGE $20.89
- IIIV $3.86
- P/E Ratio
- NAGE $34.52
- IIIV $5.70
- Revenue Growth
- NAGE 35.90
- IIIV 25.08
- 52 Week Low
- NAGE $3.18
- IIIV $21.71
- 52 Week High
- NAGE $14.69
- IIIV $33.59
- Technical
- Relative Strength Index (RSI)
- NAGE 33.55
- IIIV 52.08
- Support Level
- NAGE $7.00
- IIIV $30.90
- Resistance Level
- NAGE $7.60
- IIIV $33.59
- Average True Range (ATR)
- NAGE 0.56
- IIIV 0.96
- MACD
- NAGE -0.21
- IIIV -0.10
- Stochastic Oscillator
- NAGE 14.86
- IIIV 42.26
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About IIIV i3 Verticals Inc.
i3 Verticals Inc offers integrated payment and software solutions to small and medium-sized businesses and organizations in strategic vertical markets. Its operating segment includes Public Sector and Healthcare. The company generates maximum revenue from the Public Sector segment.